Nuo Therapeutics, Inc.
AURX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $64 | $23 | $60 | $0 |
| - Cash | $0 | $1 | $2 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $63 | $22 | $58 | -$0 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | 124.3% | 442.1% | – | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 77.8% | 79.3% | 82.9% | – |
| EBITDA | -$2 | -$3 | -$3 | $0 |
| % Margin | -173% | -503.4% | -2,757.7% | – |
| Net Income | -$2 | -$3 | -$3 | -$0 |
| % Margin | -170.2% | -521.2% | -2,695.1% | – |
| EPS Diluted | -0.051 | -0.075 | -0.076 | -0.003 |
| % Growth | 32.1% | 0.3% | -2,420% | – |
| Operating Cash Flow | -$2 | -$3 | -$4 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$2 | -$3 | -$4 | -$0 |